These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 22280969)
1. Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 (STAT3). Kandala PK; Srivastava SK BMC Med; 2012 Jan; 10():9. PubMed ID: 22280969 [TBL] [Abstract][Full Text] [Related]
2. Regulation of Janus-activated kinase-2 (JAK2) by diindolylmethane in ovarian cancer in vitro and in vivo. Kandala PK; Srivastava SK Drug Discov Ther; 2012 Apr; 6(2):94-101. PubMed ID: 22622019 [TBL] [Abstract][Full Text] [Related]
3. A potent oncolytic adenovirus selectively blocks the STAT3 signaling pathway and potentiates cisplatin antitumor activity in ovarian cancer. Han Z; Hong Z; Gao Q; Chen C; Hao Z; Ji T; Hu W; Yan Y; Feng J; Liao S; Wu P; Wang D; Wang S; Zhou J; Ma D Hum Gene Ther; 2012 Jan; 23(1):32-45. PubMed ID: 21875334 [TBL] [Abstract][Full Text] [Related]
4. IL-6 promotes nuclear translocation of HIF-1α to aggravate chemoresistance of ovarian cancer cells. Xu S; Yu C; Ma X; Li Y; Shen Y; Chen Y; Huang S; Zhang T; Deng W; Wang Y Eur J Pharmacol; 2021 Mar; 894():173817. PubMed ID: 33345849 [TBL] [Abstract][Full Text] [Related]
5. IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in ovarian cancer cells. Zou M; Zhang X; Xu C Cell Oncol (Dordr); 2016 Feb; 39(1):47-57. PubMed ID: 26510945 [TBL] [Abstract][Full Text] [Related]
6. Blocking epidermal growth factor receptor activation by 3,3'-diindolylmethane suppresses ovarian tumor growth in vitro and in vivo. Kandala PK; Wright SE; Srivastava SK J Pharmacol Exp Ther; 2012 Apr; 341(1):24-32. PubMed ID: 22205686 [TBL] [Abstract][Full Text] [Related]
7. 3,3'-Diindolylmethane suppresses ovarian cancer cell viability and metastasis and enhances chemotherapy sensitivity via STAT3 and Akt signaling in vitro and in vivo. Zou M; Xu C; Li H; Zhang X; Fan W Arch Biochem Biophys; 2018 Jul; ():. PubMed ID: 30040917 [TBL] [Abstract][Full Text] [Related]
8. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway. Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220 [TBL] [Abstract][Full Text] [Related]
9. Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1alpha autocrine loop, and reduces orthotopic tumor growth. Lang SA; Moser C; Gaumann A; Klein D; Glockzin G; Popp FC; Dahlke MH; Piso P; Schlitt HJ; Geissler EK; Stoeltzing O Clin Cancer Res; 2007 Nov; 13(21):6459-68. PubMed ID: 17975158 [TBL] [Abstract][Full Text] [Related]
10. Inhibitor of signal transducer and activator of transcription 3 (STAT3) suppresses ovarian cancer growth, migration and invasion and enhances the effect of cisplatin in vitro. Tang YJ; Sun ZL; Wu WG; Xing J; He YF; Xin DM; Han P Genet Mol Res; 2015 Mar; 14(1):2450-60. PubMed ID: 25867391 [TBL] [Abstract][Full Text] [Related]
11. Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers. Yokoyama Y; Xin B; Shigeto T; Mizunuma H J Cancer Res Clin Oncol; 2011 Aug; 137(8):1219-28. PubMed ID: 21681689 [TBL] [Abstract][Full Text] [Related]
12. Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma. Ma H; Yan D; Wang Y; Shi W; Liu T; Zhao C; Huo S; Duan J; Tao J; Zhai M; Luo P; Guo J; Tian L; Mageta L; Jou D; Zhang C; Li C; Lin J; Lv J; Li S; Lin L Cancer Sci; 2019 Mar; 110(3):950-961. PubMed ID: 30648776 [TBL] [Abstract][Full Text] [Related]
13. Abrogation of constitutive Stat3 activity circumvents cisplatin resistant ovarian cancer. Ji T; Gong D; Han Z; Wei X; Yan Y; Ye F; Ding W; Wang J; Xia X; Li F; Hu W; Lu Y; Wang S; Zhou J; Ma D; Gao Q Cancer Lett; 2013 Dec; 341(2):231-9. PubMed ID: 23962558 [TBL] [Abstract][Full Text] [Related]
14. CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells. Duan Z; Ames RY; Ryan M; Hornicek FJ; Mankin H; Seiden MV Cancer Chemother Pharmacol; 2009 Mar; 63(4):681-9. PubMed ID: 18587580 [TBL] [Abstract][Full Text] [Related]
15. Benzyl isothiocyanate suppresses pancreatic tumor angiogenesis and invasion by inhibiting HIF-α/VEGF/Rho-GTPases: pivotal role of STAT-3. Boreddy SR; Sahu RP; Srivastava SK PLoS One; 2011; 6(10):e25799. PubMed ID: 22016776 [TBL] [Abstract][Full Text] [Related]
16. HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition. Selvendiran K; Ahmed S; Dayton A; Kuppusamy ML; Rivera BK; Kálai T; Hideg K; Kuppusamy P Cancer Biol Ther; 2011 Nov; 12(9):837-45. PubMed ID: 21885917 [TBL] [Abstract][Full Text] [Related]
17. A perylene derivative regulates HIF-1α and Stat3 signaling pathways. Chen H; Guan Y; Yuan G; Zhang Q; Jing N Bioorg Med Chem; 2014 Feb; 22(4):1496-505. PubMed ID: 24485121 [TBL] [Abstract][Full Text] [Related]
18. Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells. Yue P; Zhang X; Paladino D; Sengupta B; Ahmad S; Holloway RW; Ingersoll SB; Turkson J Oncogene; 2012 May; 31(18):2309-22. PubMed ID: 21909139 [TBL] [Abstract][Full Text] [Related]
19. Cisplatin and doxorubicin repress Vascular Endothelial Growth Factor expression and differentially down-regulate Hypoxia-inducible Factor I activity in human ovarian cancer cells. Duyndam MC; van Berkel MP; Dorsman JC; Rockx DA; Pinedo HM; Boven E Biochem Pharmacol; 2007 Jul; 74(2):191-201. PubMed ID: 17498666 [TBL] [Abstract][Full Text] [Related]
20. 3,3'-Diindolylmethane inhibits VEGF expression through the HIF-1α and NF-κB pathways in human retinal pigment epithelial cells under chemical hypoxic conditions. Park H; Lee DS; Yim MJ; Choi YH; Park S; Seo SK; Choi JS; Jang WH; Yea SS; Park WS; Lee CM; Jung WK; Choi IW Int J Mol Med; 2015 Jul; 36(1):301-8. PubMed ID: 25955241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]